CELG

Celgene Corporation News Headlines

$122.36
*  
1.76
1.42%
Get CELG Alerts
*Delayed - data as of Jan. 27, 2015  -  Find a broker to begin trading CELG now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Cramer's Mad Money - 10 Things To Watch In The Week Ahead (6/13/14)
6/15/2014 6:46:00 AM - Seeking Alpha


Encouraging Long-Term Data on Celgene's Otezla - Analyst Blog
6/12/2014 10:30:00 AM - Zacks.com


Agios Initiates Trial on AG-348 - Analyst Blog
6/10/2014 3:35:00 PM - Zacks.com


Focus On Catalysts To Cash In On Biotech: Jason Kolbert
6/6/2014 1:30:00 PM - Seeking Alpha


Cramer's Lightning Round - People Will Come Back To Charles Schwab (6/5/14)
6/6/2014 5:02:00 AM - Seeking Alpha


Cramer's Mad Money - Skechers Is Totally Nailing It (6/4/14)
6/5/2014 4:41:00 AM - Seeking Alpha


A Celgene Satellite: An Interview With Alliqua CEO Dave Johnson
6/4/2014 8:19:00 AM - Seeking Alpha


Array BioPharma Collaborates with Biogen - Analyst Blog
5/29/2014 4:10:00 PM - Zacks.com


Cramer's Mad Money - Father Versus Son (5/27/14)
5/28/2014 6:23:00 AM - Seeking Alpha


Celgene Breaks Above 200-Day Moving Average - Bullish for CELG
5/27/2014 3:39:31 PM - BNK Invest


Celgene Gains Slightly on Management Changes - Analyst Blog
5/23/2014 3:12:00 PM - Zacks.com


Quanta Services Takes Over #17 Spot From Celgene
5/22/2014 10:49:39 AM - BNK Invest


Getting Bearish On Celgene The Stock, Not The Company
5/22/2014 10:10:00 AM - Seeking Alpha


Celgene Inks Licensing Deal with AADi - Analyst Blog
5/21/2014 10:30:00 AM - Zacks.com


Celgene Asserts More Revlimid Patents, Seeks New Ones To 2031
5/20/2014 6:07:00 PM - Seeking Alpha


FDA Designation for Bristol-Myers/AbbVie Candidate - Analyst Blog
5/20/2014 10:40:00 AM - Zacks.com


J.P.Morgan's Geoff Meacham Plucks Biotechs With Upside From A Down Market
5/16/2014 9:17:00 AM - Seeking Alpha


Thoughts On The Celgene Revlimid Markman Hearing
5/16/2014 9:15:00 AM - Seeking Alpha


Prothena: 4 Different Insiders Have Purchased Shares This Month
5/13/2014 11:42:00 AM - Seeking Alpha


Will Patterson (PDCO) Disappoint this Earnings Season? - Analyst Blog
5/12/2014 12:00:00 PM - Zacks.com


Celgene: Do The Revlimid Polymorph And Use Patents Matter?
5/5/2014 11:44:00 AM - Seeking Alpha


3 Biotech Beats this Earnings Season - Earnings ESP
5/1/2014 11:01:01 AM - Zacks.com


Celgene In 2015: $200 Per Share
4/29/2014 12:22:00 PM - Seeking Alpha


Addressing Revlimid Patents Questions From Celgene's Q1 2014 Call
4/28/2014 9:33:00 AM - Seeking Alpha


Cramer's Mad Money - Revenge Of The Nerds (4/24/14)
4/25/2014 6:45:00 AM - Seeking Alpha